Highly efficient Clinical Research run by a team of dedicated professionals.

How We Work

We collaborate closely with our sponsors to develop investigation protocols that comply with
all relevant regulations, with the aim of obtaining approval from the relevant health authorities.
At the outset, we develop a comprehensive plan and a clearly defined budget.
Our database provides access to the statistical data gathered during the clinical study.
Our team is highly proficient in a wide range of EDC (Electronic Data Capture) systems.
We oversee the progression of clinical studies and have established procedures for the
compilation of all data collected.
We adhere to all legal and ethical compliance regulations.
We provide assistance in the analysis of data and the preparation of clinical research reports.
We oversee all registration processes directly with
Our Organization

The Board of Directors
In accordance with international standards of corporate governance, we guarantee
transparency and accountability to the company’s shareholders, sponsors, and the general
public.
Office Services for Sponsors
To ensure the highest level of service, we have implemented a direct management system to
address the specific needs of our sponsors.

Given the complexity of the regulations governing clinical studies, patents, and health
registrations, we have established a dedicated area to address your inquiries on these matters
and any other issues related to our operations.

Cannabis Research

CANARITECH CRO
Canaritech CRO is a leading provider of research protocols tailored to the unique requirements
of cannabis medicines.
Clinical Evaluation
— We identify the right questions
By working together, we can develop a set of focused questions that will enable us to make
significant advances in the field of cannabis medicine research. A comprehensive review of
existing literature enables us to identify areas where current research is lacking. This will enable
us to make progress and thereby initiate the process for patents, clinical studies, and potential
health registrations.
Clinical Strategy
— We develop a detailed strategy
The questions that arise from the clinical evaluation assist us in developing a more
comprehensive strategy. We are therefore able to select investigators, define endpoints and
provide statistical justification. This phase of the strategy development process includes
scoping and decision-making.
Project Planning
— We develop the necessary documentation
Once a well-developed clinical strategy has been established, we can proceed with the
operational phase. At this juncture, we undertake the creation of foundational documents, the
allocation of resources, and the selection of partners.
The following documents are considered essential for the research project: a study protocol
(CIP), an informed consent form (ICF), and case report forms (CRF).
At CANARITECH, we will prepare all the necessary documentation for approval of research
protocols by the relevant authority.
Conducting the Study
— We develop the clinical phases
In this phase, we will develop the clinical phases of the project. One of our key strengths is our
ability to manage the progress of the study in compliance with the regulations issued by
Cofepris and the FDA.
Clinical Information
— We obtain the Clinical Investigation Report (CIR)
At CANARITECH we have data managers and statisticians who will analyze the collected
clinical data points and provide the results. At the end we will obtain a Clinical Investigation
Report (CIR) that will serve as a basis for your future activities.

Our Principles

Regulatory Compliance
CANARITECH is firmly committed to ensuring that all of its operations are conducted in strict
compliance with all applicable national and international regulations. Consequently, we have
established rigorous protocols and procedures to ensure compliance with Good Clinical
Practice (GCP).
As the development of our research protocols involves the participation of human beings,
CANARITECH adheres to an international standard of ethics and scientific quality in the design,
conduct, recording, and reporting of studies conducted by researchers assigned to the
protocols.
The rights, safety, and well-being of study subjects are protected in accordance with the
principles set forth in the Declaration of Helsinki and the resulting clinical data are credible.
¹ At CANARITECH, we comply with and require compliance with the Declaration of Helsinki in its
2013 version, as issued by the World Medical Association, as well as the Taipei Declaration on
Ethical Considerations for Health Databases and Biobanks.
About Us

A word from
Our Founder
The Team

Francisco Kuri Breña
Founder

Alejandro Nicolás Aguirre Oviedo

Carlos Díaz Tufinio
Past Studies

Coming Soon
Let's Collaborate

Our research staff, including study coordinators, assistants, nurses, and recruiters, undergo
regular training on regulatory compliance with the provisions issued by Cofepris.
Tell Us About your Project
If you have any inquiry or need more information, please feel free to contact us. We are here to help you every step of the way.